EyePoint Pharmaceuticals Announces Third Quarter 2019 Financial Results Release Date and Conference Call Information

NEXT STORY
The World Market for Biomarkers (2014-2024): Key Technologies, Company Profiles, Markets by Disease
PREV STORY
Interpace to Present at the American College of Gastroenterology Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Auris Medical Announces Acquisition of RNA Therapeutics Company and Plans for Strategic Repositioning

author_avatar
NASDAQ Market News

Angion Completes Enrollment in Phase 2 Study of ANG-3777 for Acute Lung Injury in Patients with COVID-19 Associated Pneumonia

author_avatar
NASDAQ Market News

Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

BERKELEY, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced ...

author_avatar
NASDAQ Market News